Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings
Details on the presentations are as follows:
2018 ACR/ARHP Annual Meeting
Title: | A Novel Recombinant Oral Urate Oxidase (UrOx) ALLN-346 Reduces Severe Hyperuricemia and Normalizes Hyperuricosuria in Nephropathic UrOx Knockout (UrOxKO) Mice | |
Session Title: | Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I | |
Session Date and Time: | Monday, October 22, 2018; 9:00 a.m. – 11:00 a.m. CT (10:00 a.m. – 12:00 p.m. ET) | |
Location: | Poster Hall, McCormick Place West | |
Abstract ID: | 1299 |
The accepted abstract is now available online on the ACR/ARHP website at www.acrabstracts.org.
ASN Kidney Week 2018
Title: | Unmet Need in Enteric Hyperoxaluria: Clinical Characteristics and Stone Burden in Patients from ALLN-177 Studies | |
Session Title: | Bone and Mineral Metabolism: Clinical - II | |
Session Date and Time: | Saturday, October 27, 2018; 10:00 a.m. – 12:00 p.m. PT (1:00 p.m.-3:00 p.m. ET) | |
Location: Abstract ID: |
Exhibit Hall, San Diego Convention Center SA-PO685 |
Title: | Evaluate the Safety and Efficacy of ALLN-177 in Patients with Enteric Hyperoxaluria (UriRox-1) | |
Session Title: | Informational Posters | |
Session Date and Time: | Thursday, October 25, 2018; 10:00 a.m. – 12:00 p.m. PT (1:00 p.m.-3:00 p.m. ET) | |
Location: Abstract ID: |
Exhibit Hall, San Diego Convention Center INFO34 |
The accepted abstracts are now available online on the ASN Kidney Week website at: https://www.asn-online.org/education/kidneyweek/2018/program-search-abstract.aspx.
About
Investor Contact
Stern Investor Relations, Inc.
212-362-1200
hannahd@sternir.com
Media Contact
Berry & Company Public Relations
212-253-8881
adaley@berrypr.com
Source: Allena Pharmaceuticals, Inc.